阿奇霉素治疗过敏性咳嗽支原体肺炎临床效果

Effect of Azithromycin With Mycoplasma Pneumonia in Allergic Cough

目的探讨阿奇霉素治疗过敏性咳嗽合并支原体肺炎患儿的临床效果。方法选择2018年2月-2019年2月本院收治的过敏性咳嗽合并支原体感染患儿80例,按照随机数字法分为两组,各40例。所有入组患儿均行对症支持治疗,对照组应用红霉素,观察组使用阿奇霉素,两组均以连续治疗7天为1疗程,2个疗程为1治疗周期。比较两组治疗后临床症状缓解时间,统计两组整体治疗效果。结果治疗后观察组临床症状中,咳嗽、咳痰、咽痒、胸闷气急缓解时间均显著早于对照组(P<0.05),观察组有效率高于对照组(P<0.05)。结论针对过敏性咳嗽合并支原体感染,应用阿奇霉素治疗,能有效的缓解患者临床症状,提高临床治疗效果。

Objective To investigate the clinical effect of azithromycin on children with mycoplasma pneumonia in allergic cough. Methods 80 children with mycoplasma infection in allergic cough from February 2018 to February 2019 were randomly divided into two group,each 40 cases. All children were received symptomatic support treatment. The control group were received erythromycin and the observation group were received azithromycin. Both groups were received continuous treatment for 7 days as a course of treatment, and the two courses of treatment were 1 for Period. Then the remission time of clinical symptoms after treatment was compared and the overall treatment effect of the two groups was counted. Results After treatment, the remission time of cough, expectoration, pharyngeal itch, chest distress and dyspnea in the observation group were significantly earlier than control group(P < 0.05), and the effective rate in the observation group was higher than control group(P < 0.05). Conclusion Azithromycin can effectively relieve the clinical symptoms with mycoplasma infection in allergic cough and improve the clinical therapeutic effect.